期刊文献+

结肠癌组织凋亡相关基因bax及其抑癌基因p^(16)表达及临床意义 被引量:1

The Expression of bax and p^(16) gene in colon tumor and their clinicopathological significance
下载PDF
导出
摘要 目的 :了解结肠癌组织中凋亡相关基因bax及其抑癌基因p16的表达 ,并探讨与临床病理学指标及预后的关系。方法 :应用LSAB法 ,将bax与 p16单克隆抗体标记 6 4例结肠癌组织 ,观察bax与 p16基因的表达情况。结果 :bax与 p16在结肠癌组织中阳性表达率分别为 4 8 4 %和 5 4 6 % ;p16的表达与结肠癌的组织类型 (x2 =13.12 ,P <0 0 5 )及 5年生存率 (x2 =4 .2 3,P <0 0 5 )有关 ;bax的阳性表达率在DukesA和B期为 81 2 % ,在C和D期为 4 2 2 % ,两者差异有统计学意义 (x2 =4 16 ,P <0 0 5 )。结论 :bax与p16基因在结肠癌中普遍表达 。 Objective:To determine the relationship between the expression of p 16 and bax gene in colon carcinoma and their clinicopathological significance and prognosis.Methods:immunohistochemical LSAB method was used to evaluate monoclone antibody of p 16 and bax gene in 64 cases of colon carcinoma.Results:The positive rates of bax and p 16 in colon carcinoma were54.6% and 48.4% respectively,positive rate of p 16was significant difference in survival (x 2=4.23,P<0.05)and between well differentiated and poorly groups of tumor (x 2=13.12,P<0.05).The positive-staining rate of bax was significant different at different Dukes stage(x 2=4.16,P<0.05).Conclusion:The expression rate of p 16 and bax gene was very high in colon carcinoma,and it might have a prognosis implications in patients with colon carcinoma.
出处 《中国现代普通外科进展》 CAS 2004年第2期101-103,共3页 Chinese Journal of Current Advances in General Surgery
关键词 结直肠肿瘤 基因 BAX 基因 P^16 病理学 临床 Colorectal neoplasmas·Gene,bax·Gene,p 16·Pathology,clinical
  • 相关文献

参考文献6

  • 1Kamb A,Gruis NA,Weaver-Feldhaus J,et al.A cell cycle regulatory potentially involed in genesis of many tumor types[J].Science,1994,264:436-440.
  • 2Serrano M,Hannor GJ,Beach D.A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4[J].Nature,1993,366:704-707.
  • 3徐美华,张桂英,谢兆霞,何春梅.吲哚美辛对结肠癌细胞CDK_2、CDK_4、p21^(WAF1/CIP1)、Bcl-2及Bax蛋白表达的影响[J].中华消化杂志,2002,22(10):605-607. 被引量:15
  • 4Sermadiras S,Dumas M,Joly-Berville R,et al.Expression of bcl-2 and bax in cultured normal human keratinocytes and melanocytes:relationship to differentiation and melanogenesis[J].Br J Dermatol,1997,37:883-889.
  • 5Brown JM,Wouters BG.Apoptosis,p53,and tumor cell sensitivity to anticancer agents.Cancer Res,1999,59:1391-1399.
  • 6Krajewski S,Krajewska M,Shabaik A,et al.Immunohistochemical determination of in vivo distribution of bax,a dominant inhibitor of bcl-2[J].Am J Pathol,1994,145:1323-1336.

二级参考文献10

  • 1Shiff SJ, Qiao, Tsai LL, et al.Sulindac sulfide, an aspirin-likecompound, inhibits prolifcration, causes cell cyclcquiescence, andinduces apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest, 1995,96:491-503.
  • 2Shiff SJ, Koutsos MI, Qiao L, et al. Nonsteroidal antiinflammatory drugs inhibitthe proliferation of colon adenocarcinoma cells:effects on cell cycle and apoptosis. ExpCell Res, 1996, 222:179-188.
  • 3Lonnroth C, Andersson M, Lundholm K. Indomethacin andtelomerase activity in tumorgrowth retardation. Int J Oncol,2001, 18:929-937.
  • 4Li Y, Bhuiyan M, Mohammad RM, et al. Induction of apoptosisin breast cancer cellsby TPA. Oncogene, 1998, 17: 2915-2920.
  • 5Zhang G, Tu C, Zhang G, et al. Indomethacin induces apoptosisand inhibitsproliferation in chronic myeloid lenk cells. Leuk Res,2000, 24: 385-392.
  • 6Brown J M, Wouters BG. Apoptosis, p53, and tumor cell sensitivity to anticanceragents. Cancer Res, 1999, 59:1391-1399.
  • 7Koshiji M, Adachi Y, Sogom S, et al. Apoptosis of colorectal adenocarcinoma(COLO-201) by tumour necrosis factor-alpha (TNFα) and/or interferon-gamma (IFN-γ),resulting from down-modulation of Bcl-2 expression. Clin Exp Immunol, 1998, 111:211-218.
  • 8张桂英,段朝军,施家琦,冷爱民.消炎痛抗肿瘤作用及体外增敏作用的研究[J].湖南医科大学学报,1997,22(6):478-482. 被引量:15
  • 9张桂英,冷爱民,贺智敏,唐丽安.消炎痛抑制人结肠癌细胞增殖和诱导凋亡的研究[J].中国现代医学杂志,1998,8(12):1-3. 被引量:9
  • 10张桂英,段晓明,袁伟建,何春梅.吲哚美辛诱导结肠癌细胞凋亡的分子机制[J].中华消化杂志,2000,20(4):267-267. 被引量:10

共引文献14

同被引文献15

  • 1Pietenpol JA,Bohlander SK,Sato Y, et al.Assignment of the human p27 kipl gene to 12p13 and its arudysis in kukemias[].Cancer Research.1997
  • 2Qin LF,Ng IO.Expression of p27kipl and p21(WAF1/CIPI)in primary hepatocelluar carcinoma; clinieopathologic corelation and survival andalysis[].Human Pathology.2001
  • 3Vidal A,Koff A.Cell-cycle inhibitors: three families united by a common cause[].Gene.2000
  • 4Polyak K,Lee M H,Erdjurment-Bromage H,et al.Cloning of P27, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals[].Cell.1994
  • 5Sharpless NE,Bardeesy N,Lee KH,et al.Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis[].Nature.2001
  • 6KAWAMATA N,MOROSETTI R,MILLER C W,et al.Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies[].Cancer Research.1995
  • 7Ponce-Castaneda MV,Lee MH,Latres E,et al.p27Kipl: chromosomal mapping to 12p12-12p13. 1 and absence of mutations in human tumors[].Cancer Research.1995
  • 8Hui AM,Li X,Shi YZ,et al.p27(Kip1) expression in normal epithelia, precancerous lesions, and carcinomas of the gallbladder: association with cancer progression and prognosis[].Hepatology.2000
  • 9Piao Z,Park C,Lee JS,et al.Homozygous deletions of the CDKN2 gene and loss of heterozygosity of 9p in primary hepatocellular carcinoma[].Cancer Letters.1998
  • 10Jin M,Piao Z,Kim NG,et al.p16 is a major inactivation target in hepatocellular carcinoma[].Cancer.2000

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部